These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12428230

  • 1. Matrix homeostasis in aging normal human ankle cartilage.
    Aurich M, Poole AR, Reiner A, Mollenhauer C, Margulis A, Kuettner KE, Cole AA.
    Arthritis Rheum; 2002 Nov; 46(11):2903-10. PubMed ID: 12428230
    [Abstract] [Full Text] [Related]

  • 2. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR, Okouneff S, Ionescu M, Poole AR.
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [Abstract] [Full Text] [Related]

  • 3. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
    Aurich M, Squires GR, Reiner A, Mollenhauer JA, Kuettner KE, Poole AR, Cole AA.
    Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
    [Abstract] [Full Text] [Related]

  • 4. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [Abstract] [Full Text] [Related]

  • 5. Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.
    Aurich M, Mwale F, Reiner A, Mollenhauer JA, Anders JO, Fuhrmann RA, Kuettner KE, Poole AR, Cole AA.
    Arthritis Rheum; 2006 Jan; 54(1):244-52. PubMed ID: 16388531
    [Abstract] [Full Text] [Related]

  • 6. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [Abstract] [Full Text] [Related]

  • 8. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, Poole AR.
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [Abstract] [Full Text] [Related]

  • 9. Early post-traumatic osteoarthritis-like changes in human articular cartilage following rupture of the anterior cruciate ligament.
    Nelson F, Billinghurst RC, Pidoux I, Reiner A, Langworthy M, McDermott M, Malogne T, Sitler DF, Kilambi NR, Lenczner E, Poole AR.
    Osteoarthritis Cartilage; 2006 Feb; 14(2):114-9. PubMed ID: 16242972
    [Abstract] [Full Text] [Related]

  • 10. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS.
    J Clin Invest; 1997 Jul 01; 100(1):93-106. PubMed ID: 9202061
    [Abstract] [Full Text] [Related]

  • 11. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
    Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.
    Arthritis Rheum; 2005 Mar 01; 52(3):885-91. PubMed ID: 15751093
    [Abstract] [Full Text] [Related]

  • 12. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T, Poole AR.
    Arthritis Rheum; 2002 Jan 01; 46(1):138-48. PubMed ID: 11817586
    [Abstract] [Full Text] [Related]

  • 13. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.
    Matrix Biol; 2006 Sep 01; 25(7):419-29. PubMed ID: 16919430
    [Abstract] [Full Text] [Related]

  • 14. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR.
    Arthritis Rheum; 2005 Jan 01; 52(1):128-35. PubMed ID: 15641080
    [Abstract] [Full Text] [Related]

  • 15. Changes in content and synthesis of collagen types and proteoglycans in osteoarthritis of the knee joint and comparison of quantitative analysis with Photoshop-based image analysis.
    Lahm A, Mrosek E, Spank H, Erggelet C, Kasch R, Esser J, Merk H.
    Arch Orthop Trauma Surg; 2010 Apr 01; 130(4):557-64. PubMed ID: 19838720
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
    Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR.
    J Clin Invest; 1997 Apr 01; 99(7):1534-45. PubMed ID: 9119997
    [Abstract] [Full Text] [Related]

  • 17. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ, Little CB, King LE, Hookfin EB, Brown KK, Heitmeyer SA, Caterson B, Poole AR, Taiwo YO.
    Osteoarthritis Cartilage; 2004 Sep 01; 12(9):720-8. PubMed ID: 15325638
    [Abstract] [Full Text] [Related]

  • 18. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis.
    Laverty S, Okouneff S, Ionescu M, Reiner A, Pidoux I, Webber C, Rossier Y, Billinghurst RC, Poole AR.
    J Orthop Res; 2002 Nov 01; 20(6):1282-9. PubMed ID: 12472241
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
    Wang J, Elewaut D, Veys EM, Verbruggen G.
    Arthritis Rheum; 2003 May 01; 48(5):1281-91. PubMed ID: 12746901
    [Abstract] [Full Text] [Related]

  • 20. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS, Ionescu M, Jugessur H, Poole AR.
    Arthritis Rheum; 1999 Mar 01; 42(3):534-44. PubMed ID: 10088777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.